Skip to main content
Clinical Trials/NCT02337790
NCT02337790
Completed
Not Applicable

Necklace-Shaped Sensor for Non-Invasive Monitoring of Fluids, Heart Rate, Heart Rate Variability, and Respiration Rate in Patients With a Pacemaker, Implanted Cardioverter-Defibrillator, or Ventricular Assist Device

Baxter Healthcare Corporation1 site in 1 country109 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Baxter Healthcare Corporation
Enrollment
109
Locations
1
Primary Endpoint
Number of Patients with Interference between implanted devices and CoVa Monitoring System
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This study is designed to validate the use of the CoVa Monitoring System in subjects with implanted devices.

Detailed Description

The study had the following objectives: 1. Verify that the CoVa Monitoring System does not interfere with implanted devices. 2. Verify that implanted devices do not interfere with the functions of the CoVa Monitoring System. 3. Verify that the CoVa Monitoring System fits on a wide variety of body types.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
May 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject is between 21 (twenty-one) and 95 (ninety-five) years of age at screening.
  • Subject has a pacemaker, implanted cardioverter-defibrillator, or ventricular assist device.
  • Subject and/or legally authorized person/representative is willing to undergo the Informed Consent process prior to enrollment in the study.
  • Subject is a candidate for this study based on the PI's opinion and knowledge of the subject's condition.

Exclusion Criteria

  • Subject is participating in another clinical study that may affect the results of either study.
  • Subject is unable or not willing to wear electrode patches as required.
  • Subject has skin sensitivity to adhesive or hydrogel materials used in electrode patches.
  • Subject is considered by the PI to be medically unsuitable for study participation.

Outcomes

Primary Outcomes

Number of Patients with Interference between implanted devices and CoVa Monitoring System

Time Frame: One time for up to 15 minutes during a clinic visit for device interrogation

Study Sites (1)

Loading locations...

Similar Trials